Louis Ferrari, President and CEO at SAVIENT PHARMACEUTICALS INC (SVNT), sold 375 shares at $0.99 ($371) on 2013-02-25, disclosed to the SEC on 2013-02-25.
Scheduled sale ($371) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SVNT | SELL | 2012-11-27 | $1K | — | Filing → |
| SVNT | SELL | 2012-08-24 | $984 | — | Filing → |
| SVNT | SELL | 2012-05-22 | $772 | — | Filing → |